Codexis (CDXS) Net Cash Flow (2010 - 2026)
Codexis (CDXS) posted quarterly Net Cash Flow of -$14.3 million for Q1 2026, down 1412.18% year-over-year from $1.1 million in Q1 2025, and down 154.94% quarter-over-quarter from $26.0 million in Q4 2025.
Codexis (CDXS) Net Cash Flow (2010 - 2026) Analysis & Trends
Codexis' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$14.3 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 1412.18% year-over-year to -$14.3 million; the TTM figure through Mar 2026 stood at $18.7 million (up 147.11% YoY), while the FY2025 annual figure was $32.1 million, up 169.88% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$14.3 million, down from $26.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $26.0 million in Q4 2025, with the low at -$39.5 million in Q2 2024.
- The 5-year median for Net Cash Flow is -$7.1 million (2024), against an average of -$4.7 million.
- The sharpest annual moves came in 2022 and 2026: Net Cash Flow jumped 320.93% in 2022, then plunged 1412.18% in 2026.
- Codexis' Net Cash Flow stood at $5.3 million in 2022, then plunged by 287.8% to -$9.9 million in 2023, then slumped by 83.22% to -$18.2 million in 2024, then surged by 242.78% to $26.0 million in 2025, then sank by 154.94% to -$14.3 million in 2026.
- Business Quant data shows CDXS's Net Cash Flow at -$14.3 million in Q1 2026, $26.0 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | Codexis | 143.86 Mn | 88.95 Mn | 11.40 Mn | -9.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.40 Mn |
| Jun 30, 2026 | -9.40 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | 25.99 Mn |
| Dec 31, 2025 | 25.99 Mn |
| Sep 30, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.43 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | -944,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Dec 31, 2024 | -18.20 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Jun 30, 2024 | -39.45 Mn |
| Jun 30, 2024 | -39.45 Mn |
| Mar 31, 2024 | -7.07 Mn |
| Mar 31, 2024 | -7.07 Mn |